162 related articles for article (PubMed ID: 23657981)
1. Detection of serum Alu element hypomethylation for the diagnosis and prognosis of glioma.
Chen J; Gong M; Lu S; Liu F; Xia L; Nie D; Zou F; Shi J; Ju S; Zhao L; Zuo H; Qi J; Shi W
J Mol Neurosci; 2013 Jun; 50(2):368-75. PubMed ID: 23657981
[TBL] [Abstract][Full Text] [Related]
2. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
[TBL] [Abstract][Full Text] [Related]
3. Alu and Satα hypomethylation in Helicobacter pylori-infected gastric mucosae.
Yoshida T; Yamashita S; Takamura-Enya T; Niwa T; Ando T; Enomoto S; Maekita T; Nakazawa K; Tatematsu M; Ichinose M; Ushijima T
Int J Cancer; 2011 Jan; 128(1):33-9. PubMed ID: 20602342
[TBL] [Abstract][Full Text] [Related]
4. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury.
Udomsinprasert W; Sakuntasri W; Jittikoon J; Chaikledkaew U; Honsawek S; Chantratita W; Wattanapokayakit S; Mahasirimongkol S
Emerg Microbes Infect; 2021 Dec; 10(1):1862-1872. PubMed ID: 34467830
[TBL] [Abstract][Full Text] [Related]
5. Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma.
Gong M; Shi W; Qi J; Shao G; Shi Z; Wang J; Chen J; Chu R
Oncotarget; 2017 Sep; 8(44):76797-76806. PubMed ID: 29100349
[TBL] [Abstract][Full Text] [Related]
6. Alu hypomethylation in smoke-exposed epithelia and oral squamous carcinoma.
Puttipanyalears C; Subbalekha K; Mutirangura A; Kitkumthorn N
Asian Pac J Cancer Prev; 2013; 14(9):5495-501. PubMed ID: 24175848
[TBL] [Abstract][Full Text] [Related]
7. Methylation status of alu repetitive elements in children with tuberculosis disease.
Maruthai K; Subramanian M
Int J Mycobacteriol; 2018; 7(3):242-246. PubMed ID: 30198503
[TBL] [Abstract][Full Text] [Related]
8. Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples.
Buj R; Mallona I; Díez-Villanueva A; Barrera V; Mauricio D; Puig-Domingo M; Reverter JL; Matias-Guiu X; Azuara D; Ramírez JL; Alonso S; Rosell R; Capellà G; Perucho M; Robledo M; Peinado MA; Jordà M
Oncotarget; 2016 Mar; 7(9):10536-46. PubMed ID: 26859682
[TBL] [Abstract][Full Text] [Related]
9. POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.
Liu X; Tang H; Zhang Z; Li W; Wang Z; Zheng Y; Wu M; Li G
Brain Res; 2011 May; 1391():125-31. PubMed ID: 21439273
[TBL] [Abstract][Full Text] [Related]
10. Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas.
Xiang S; Liu Z; Zhang B; Zhou J; Zhu BD; Ji J; Deng D
BMC Cancer; 2010 Feb; 10():44. PubMed ID: 20163738
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
12. Spreading of Alu methylation to the promoter of the MLH1 gene in gastrointestinal cancer.
Wang X; Fan J; Liu D; Fu S; Ingvarsson S; Chen H
PLoS One; 2011; 6(10):e25913. PubMed ID: 22022465
[TBL] [Abstract][Full Text] [Related]
13. F10 gene hypomethylation, a putative biomarker for glioma prognosis.
Liu X; Tang H; Wang Z; Huang C; Zhang Z; She X; Wu M; Li G
J Neurooncol; 2012 May; 107(3):479-85. PubMed ID: 22160665
[TBL] [Abstract][Full Text] [Related]
14. Global DNA hypomethylation and the expression profile of DNA methyltransferase genes in late-onset neonatal sepsis.
Sankar S; Maruthai K; Zachariah B; Bethou A
Epigenomics; 2022 Jun; 14(11):671-682. PubMed ID: 35587102
[No Abstract] [Full Text] [Related]
15. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
Bollati V; Fabris S; Pegoraro V; Ronchetti D; Mosca L; Deliliers GL; Motta V; Bertazzi PA; Baccarelli A; Neri A
Carcinogenesis; 2009 Aug; 30(8):1330-5. PubMed ID: 19531770
[TBL] [Abstract][Full Text] [Related]
16. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors).
Choi IS; Estecio MR; Nagano Y; Kim DH; White JA; Yao JC; Issa JP; Rashid A
Mod Pathol; 2007 Jul; 20(7):802-10. PubMed ID: 17483816
[TBL] [Abstract][Full Text] [Related]
18. The association between Alu hypomethylation and the severity of hypertension.
Thongsroy J; Mutirangura A
PLoS One; 2022; 17(7):e0270004. PubMed ID: 35802708
[TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients.
Nakkuntod J; Avihingsanon Y; Mutirangura A; Hirankarn N
Clin Chim Acta; 2011 Jul; 412(15-16):1457-61. PubMed ID: 21496453
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.
Barry KH; Moore LE; Liao LM; Huang WY; Andreotti G; Poulin M; Berndt SI
Prostate; 2015 Nov; 75(15):1718-25. PubMed ID: 26250474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
